Voltar à tendência do dia: Seleção do Paquistão veste rosa hoje para incentivar exames precoces de câncer de mama
Ranking Poly · da tendência do dia

Taxa de sobrevivência ao câncer de mama por país: 9 nações

A Organização Mundial da Saúde (OMS) estima sobrevivência de cinco anos ao câncer de mama de 50–59% no Paquistão, enquanto a estimativa mais antiga do estudo CONCORD-3 para a Austrália foi de 89,5%.

  • Nº 1: Pakistan
  • 9 posições

01Lista final

As IAs líderes montaram cada uma a sua lista de dez, de forma independente. Aqui está um resultado fácil de conferir: cada posição tem um motivo, uma fonte e a lista das IAs que a incluíram.

Ordem: da maior para a menor concordância entre as IA.

Uma etiqueta forte significa que essa IA pôs o item na sua lista. Uma esmaecida, que não pôs.

  1. 1

    Pakistan

    O modelo da OMS aponta sobrevivência de cinco anos de 50–59%; uma coorte de hospital em Lahore encontrou 49,4% no estágio III, mas excluiu o estágio IV e não é representativa do país.

    Incluíram: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Não incluíram: Kimi.

    Nas listas delas: Claude: 1 · ChatGPT: 1 · Meta: 2 · Nemotron: 7 · Gemini: 9 · DeepSeek: 3 · Wenxin: 6 · Qwen: 1

    O que cada IA notou 8
    • Claudeposição 1

      Pakistan has the highest breast cancer mortality-to-incidence ratio of any Asian cricket nation I could compute (0.54): 18.6 deaths for every 34.2 new cases per 100,000 women.

    • ChatGPTposição 1

      WHO's model puts five-year survival in the 50–59% band; a 2020 Lahore hospital cohort found nearly half of its non-metastatic patients already at stage III.

      Fonte ↗
    • Metaposição 2

      1 in 9 lifetime risk, 70% stage III-IV, survival 50%, ASMR 18.6 highest in Asia, no organized screening

      Fonte ↗
    • Nemotronposição 7

      5-yr survival ~55% (hospital); 30% early-stage; MIR 0.53 — highest MIR in cricket world; <5% screening; 70% present locally advanced

    • Geminiposição 9

      Carries Asia's highest mortality-to-incidence gap, where an estimated 65%–70% of women present with late-stage tumors and 5-year survival averages ~50%–58%.

    • DeepSeekposição 3

      Sixty percent of Pakistani breast cancer patients present with locally advanced disease, and the mortality-to-incidence ratio is 0.61 — one of the highest in Asia.

    • Wenxinposição 6

      Below fifty percent survive five years — one of the largest early-detection gaps on any cricket-playing map

    • Qwenposição 1

      With the highest incidence rate in Asia, Pakistan sees half its patients survive past five years because early checks remain a privilege.

    8 IAs colocaram aqui
    Fonte ↗
  2. 2

    India

    O CONCORD-3 registrou sobrevivência líquida de cinco anos de 66,1% para 2010–2014; o modelo mais novo da OMS coloca a Índia na faixa de 60–69%.

    Incluíram: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Não incluíram: Kimi.

    Nas listas delas: Claude: 2 · ChatGPT: 3 · Meta: 5 · Nemotron: 6 · Gemini: 8 · DeepSeek: 4 · Wenxin: 5 · Qwen: 2

    O que cada IA notou 8
    • Claudeposição 2

      CONCORD-3 gives India the lowest breast cancer five-year survival it reports, 66.1%, against 89.5% in Australia and 90.2% in the US.

      Fonte ↗
    • ChatGPTposição 3

      The WHO 2017–21 model puts five-year survival at 60–69%, while a GLOBOCAN-based estimate records 98,337 breast-cancer deaths in 2022.

      Fonte ↗
    • Metaposição 5

      192,020 cases 98,337 deaths 2022 MIR 0.51 double Australia, 60% late, survival 66.1% lowest among high-volume cricket nations

    • Nemotronposição 6

      5-yr survival ~66% (hospital); 40% early-stage; MIR 0.31 — no national screening; 60%+ present at stage III–IV in rural areas

    • Geminiposição 8

      Loses the early detection advantage with a 5-year survival of 66.1% as more than 60% of women arrive at hospitals already in Stage III or IV.

    • DeepSeekposição 4

      India’s five-year net survival is 66.1%, and some hospital series report 62% of patients arriving with locally advanced breast cancer — a gap driven by screening uptake below 1%.

      Fonte ↗
    • Wenxinposição 5

      Sixty-six percent survive, but only about 30% of cases are caught early in a country of 1.4 billion

    • Qwenposição 2

      More than half of India's cases are caught at stage III or IV, dragging the national 5-year survival rate down to 66% despite rising incidence.

      Fonte ↗
    8 IAs colocaram aqui
    Fonte ↗
  3. 3

    Bangladesh

    A OMS situa a sobrevivência na faixa de 60–69%, mas as fontes fornecidas não trazem uma proporção nacional comparável por estágio nem o valor exato de sobrevivência.

    Incluíram: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Não incluíram: Kimi.

    Nas listas delas: Claude: 3 · ChatGPT: 4 · Meta: 4 · Nemotron: 8 · Gemini: 10 · DeepSeek: 5 · Wenxin: 9 · Qwen: 3

    O que cada IA notou 8
    • Claudeposição 3

      Bangladesh has one of the lowest incidence rates here (15.2 per 100,000) but nearly half of those diagnosed die (MIR about 0.50).

    • ChatGPTposição 4

      WHO places five-year survival in the 60–69% band, but national stage and population-survival measurement remain sparse.

      Fonte ↗
    • Metaposição 4

      14,836 cases 2022, no population screening, ∼65% late stage, survival ∼55% estimated

      Fonte ↗
    • Nemotronposição 8

      5-yr survival ~58% (hospital); 35% early-stage; MIR 0.41 — no screening programme; cancer stigma delays presentation by 6–12 months

    • Geminiposição 10

      Faces acute shortages in diagnostic mammography, leaving more than 70% of female breast cancer cases diagnosed at locally advanced or metastatic stages.

    • DeepSeekposição 5

      Bangladesh has a mortality-to-incidence ratio of about 0.50 and a five-year survival estimate near 58% in a triple-negative cohort — early detection is rare and advanced disease common.

    • Wenxinposição 9

      Just over sixty percent survive five years; with one oncologist per 100,000 people, late-stage diagnosis is the norm

    • Qwenposição 3

      Lacking a national screening program, Bangladesh faces a massive detection gap where most women only seek help once the disease has advanced.

    8 IAs colocaram aqui
    Fonte ↗
  4. 4

    Australia

    O CONCORD-3 registrou sobrevivência líquida de cinco anos de 89,5% para 2010–2014; é um parâmetro de alta sobrevivência, embora medidas nacionais mais recentes usem métodos diferentes.

    Incluíram: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Não incluíram: Kimi.

    Nas listas delas: Claude: 9 · ChatGPT: 10 · Meta: 10 · Nemotron: 1 · Gemini: 1 · DeepSeek · Wenxin: 2 · Qwen: 9

    O que cada IA notou 8
    • Claudeposição 9

      Australia's five-year breast cancer survival is 89.5% (CONCORD-3) to 93% (AIHW), and half of eligible women still don't use the screening programme.

      Fonte ↗
    • ChatGPTposição 10

      Australia's 2010–14 CONCORD net survival was 89.5%, while its latest OECD screening series shows 51.3% coverage in 2023—high outcomes do not mean every eligible woman is screened.

    • Metaposição 10

      Survival 89.5% vs 40% South Africa, ASIR 101.47 ASMR 12.3, screening 51.7% but >60% early stage meets WHO target – smallest gap

    • Nemotronposição 1

      91.5% 5-yr survival; 72% early-stage (I–II); MIR 0.14 — best in cricket world; screening 54% but high symptom awareness drives early presentation

      Fonte ↗
    • Geminiposição 1

      Leads world cricket with a 5-year net survival of 89.5%–91.5% and over 75% of breast cancers diagnosed at early Stage I or II.

      Fonte ↗
    • DeepSeek

      Na própria lista tem outro nome: abra a lista completa.

    • Wenxinposição 2

      Ninety-one percent survive five years, but the country still loses 3,000 women a year to a disease caught too late

    • Qwenposição 9

      A 90% five-year survival rate reflects decades of screening, yet rural and Indigenous communities still face delayed diagnoses that skew the national averages.

    8 IAs colocaram aqui
    Fonte ↗
  5. 5

    England

    O CONCORD-3 e os dados nacionais de rastreamento apontam resultados melhores do que as entradas com maior diferença, mas os números se referem a períodos e medidas diferentes.

    Incluíram: Claude, Meta, Nemotron, Gemini, Kimi, DeepSeek, Wenxin, Qwen. Não incluíram: ChatGPT.

    Nas listas delas: Claude: 8 · Meta: 9 · Nemotron: 2 · Gemini: 3 · Kimi: 8 · DeepSeek: 10 · Wenxin: 1 · Qwen: 8

    O que cada IA notou 8
    • Claudeposição 8

      In England, stage 1 breast cancer has almost 100% five-year survival and stage 2 about 90%; the gap is in who is caught that early, with 70.6% screening uptake.

      Fonte ↗
    • Metaposição 9

      ASIR 94.0 ASMR 14.0 2022, screening 71.8% coverage 2024/25 recovering post-COVID, survival ∼85.6%

    • Nemotronposição 2

      89.5% 5-yr survival; 70% early-stage; MIR 0.19 — NHS screening 65% catches most, but deprived areas lag 10–15 pts behind

      Fonte ↗
    • Geminiposição 3

      Records an 85.6% five-year net survival, catching over 70% of tumors early via the NHS population-based mammography scheme.

      Fonte ↗
    • Kimiposição 8

      Six in ten English breast cancers are stage I at diagnosis — the screening programme finds them before symptoms, which is exactly what the pink days in Lahore and Karachi are trying to build.

      Fonte ↗
    • DeepSeekposição 10

      England’s five-year survival is about 86%, but 8.4% of cases are still diagnosed at stage III and 4.8% at stage IV — a smaller but persistent late-diagnosis tail.

    • Wenxinposição 1

      Eighty-seven in a hundred women survive five years — the best net survival among test-playing nations and a gap of 24 points over Pakistan

    • Qwenposição 8

      England catches 85% of cases early, but a post-pandemic dip in screening coverage below 65% threatens to widen the gap for marginalized groups.

      Fonte ↗
    8 IAs colocaram aqui
    Fonte ↗
  6. 6

    Zimbabwe

    Um estudo de registro de Harare relatou sobrevivência relativa de cinco anos de 52%; é resultado de um registro de uma cidade, não uma estimativa nacional, e difere dos outros períodos de estudo citados.

    Incluíram: Claude, Nemotron, Kimi, DeepSeek, Wenxin. Não incluíram: ChatGPT, Meta, Gemini, Qwen.

    Nas listas delas: Claude: 4 · Nemotron: 10 · Kimi: 2 · DeepSeek: 2 · Wenxin: 10

    O que cada IA notou 5
    • Claudeposição 4

      Zimbabwe has no published survival figure, and the only evidence is regional: Eastern Africa's breast cancer MIR is 0.54, the same as Pakistan's.

      Fonte ↗
    • Nemotronposição 10

      5-yr survival ~45% (hospital); 25% early-stage; MIR 0.61 — worst in cricket world; no radiotherapy since 2020; screening <2%

    • Kimiposição 2

      In Harare's registry, fewer than half of women survived five years; in Bulawayo's, barely one in five saw three.

      Fonte ↗
    • DeepSeekposição 2

      Five-year relative survival for breast cancer in Zimbabwe has been reported as low as 37.9% in one registry analysis and 59% in a later SURVCAN analysis — still far below the 85% benchmark.

      Fonte ↗
    • Wenxinposição 10

      Not a Test nation, but included for the gap: below 40% survive five years, making the cricket pitch almost irrelevant to the outcome

    5 IAs colocaram aqui
    Fonte ↗
  7. 7

    Sri Lanka

    O registro hospitalar do instituto nacional de câncer encontrou 66% nos estágios I–II em 2016–2020; esse registro atende cerca de 40% dos pacientes com câncer do país.

    Incluíram: Claude, Meta, Nemotron, DeepSeek, Qwen. Não incluíram: ChatGPT, Gemini, Kimi, Wenxin.

    Nas listas delas: Claude: 7 · Meta: 7 · Nemotron: 5 · DeepSeek: 8 · Qwen: 7

    O que cada IA notou 5
    • Claudeposição 7

      Two-thirds (66%) of Sri Lankan breast cancers in the National Cancer Institute registry were found at stage I–II, close to the WHO's 60% goal.

    • Metaposição 7

      3,955 cases 2022, survival ∼70% estimated, improving but 30-40% late still below WHO 60% early target

      Fonte ↗
    • Nemotronposição 5

      5-yr survival ~75% (hospital-based); 55% early-stage; MIR 0.22 — well-woman clinic network gives 30% screening but pathology delays upstage

    • DeepSeekposição 8

      Sri Lanka’s breast cancer-specific survival is about 78.8%, better than India or Pakistan, but advanced presentations remain common and the mortality-to-incidence ratio is 0.41.

      Fonte ↗
    • Qwenposição 7

      Sri Lanka boasts a 75% survival rate—higher than its neighbors—but still falls short of the WHO’s 60% early-stage diagnosis benchmark.

    5 IAs colocaram aqui
    Fonte ↗
  8. 8

    Nigeria

    O modelo da OMS estima sobrevivência de cinco anos de 27,7%, mas sua análise de sensibilidade sobe para 47,7% sem os dados de registros hospitalares — uma incerteza particularmente grande.

    Incluíram: ChatGPT, Nemotron, DeepSeek. Não incluíram: Claude, Meta, Gemini, Kimi, Wenxin, Qwen.

    Nas listas delas: ChatGPT: 7 · Nemotron · DeepSeek

    O que cada IA notou 3
    • ChatGPTposição 7

      WHO's model estimates 27.7% five-year survival, but its sensitivity estimate jumps to 47.7% without hospital-based data—a particularly large uncertainty.

      Fonte ↗
    • Nemotron

      Na própria lista tem outro nome: abra a lista completa.

    • DeepSeek

      Na própria lista tem outro nome: abra a lista completa.

    3 IAs colocaram aqui
    Fonte ↗
  9. 9

    Afghanistan

    Uma IA citou 56% em estágios III–IV entre pacientes afegãos registrados no Paquistão; as respostas fornecidas não estabeleceram nenhum número nacional comparável de sobrevivência.

    Incluíram: Meta, DeepSeek. Não incluíram: Claude, ChatGPT, Nemotron, Gemini, Kimi, Wenxin, Qwen.

    Nas listas delas: Meta: 3 · DeepSeek: 1

    O que cada IA notou 2
    • Metaposição 3

      No national registry, low HDI, estimated incidence 23.5, survival ∼45%, <20% early stage vs WHO 60% target

      Fonte ↗
    • DeepSeekposição 1

      Five-year survival is estimated at 40–49%, and 56% of Afghan breast cancer patients in a cross-border registry presented at stage III or IV — the widest early-detection gap in this ranking.

      Fonte ↗
    2 IAs colocaram aqui
    Fonte ↗

Mais sobre os três primeiros ↓

02Mais sobre os três primeiros

O ranking está acima. Aqui há mais sobre os três primeiros lugares: o que são, por que estão aqui e o que vale saber.

Pakistan’s estimate is for 2017–2021, India’s exact figure is for 2010–2014, and Bangladesh has only a band.

1Pakistan

Nº 1 — Pakistan. Nas listas de 8 de 9 IAs; posição mediana ali: 2.5. The AIs placed Pakistan first because they cited low survival, late diagnosis and high mortality relative to new cases.

Você sabia?

  • The Edhi Foundation’s ambulance service began in 1948. Guinness World Records lists it as the largest volunteer ambulance organisation. — (voice only)

    Fonte ↗
O que é
Pakistan’s breast cancer survival estimate is modelled by WHO.
Seu diferencial
Its 50–59% band is below the 60–69% bands for India and Bangladesh.
Quem deve saber
Useful to readers comparing country survival estimates and their limits.
  • Five-year breast cancer survival50–59%
Por que está aqui

  • WHO estimates Pakistan’s five-year breast cancer survival at 50–59% for 2017–2021, below India and Bangladesh, both in the 60–69% band. — (voice only)

    Fonte ↗

  • In one Lahore hospital cohort, 49.4% of patients had stage III cancer. The study excluded stage IV cases, so this is not a national figure. — (voice only)

    Fonte ↗
História

  • In 1947, Pakistan began amid a huge refugee crisis after Partition. Its first census, in 1951, recorded 7 million refugees—20 percent of the population at the time.

    Fonte ↗
Para ter em mente

  • The WHO figure is modelled, combining registry data, country submissions and other factors. It is not a direct national registry measurement.

    Fonte ↗ ✓ confirmado por várias IAs
O que as pessoas dizem

  • “If I am alive today, it is because I talked about it openly and refused to be passive about it,” she told DW. — Gulnaz Ayaz

    Fonte ↗
Onde saber mais

  • Open the WHO’s country survival estimates and look up Pakistan first; check the estimate’s year and method alongside the survival band. — (voice only)

    Fonte ↗
Comparar os três primeiros ↓

2India

Nº 2 — India. Nas listas de 8 de 9 IAs; posição mediana ali: 4.5. The AIs placed India here because they cited 66.1% survival and frequent late diagnosis.

Você sabia?

  • India’s Mars Orbiter Mission reached Mars orbit on its first attempt, on 24 September 2014. It remained operational for more than eight years, though it was designed for six months. — (voice only)

    Fonte ↗
O que é
India’s survival is reported as an exact older figure and a newer WHO band.
Seu diferencial
Its 66.1% figure is more exact than Bangladesh’s band.
Quem deve saber
Useful to readers comparing survival reports across years and methods.
  • Five-year breast cancer survival66.1%
Por que está aqui

  • WHO’s newer estimate puts India in the 60–69% five-year survival band for 2017–2021, the same band as Bangladesh and above Pakistan’s 50–59%. — (voice only)

    Fonte ↗
História

  • In 1947, Britain’s rushed Partition created independent India and Pakistan. The border was announced two days after independence, leaving people uncertain about which country they would be in.

    Fonte ↗
Para ter em mente

  • CONCORD-3’s 66.1% figure is for Karunagappally, not all of India, and covers women diagnosed in 2010–2014.

    Fonte ↗

  • The newer WHO estimate uses a model for 2017–2021, combining observed registry estimates with other data and regional trends; it is not a national registry count.

    Fonte ↗
O que as pessoas dizem

  • “I thought life is infinite, which it isn’t” — Vogue India interviewee

    Fonte ↗
Onde saber mais

  • Download India’s ICMR annual report and look for the breast cancer survival study across 11 population-based registries; compare its regional and stage findings. — (voice only)

    Fonte ↗
Comparar os três primeiros ↓

3Bangladesh

Nº 3 — Bangladesh. Nas listas de 8 de 9 IAs; posição mediana ali: 4.5. The AIs placed Bangladesh here because they cited low screening and late diagnosis, while exact national survival data was unavailable.

Você sabia?

  • The Bangladesh part of the Sundarbans is the world’s largest contiguous mangrove forest. UNESCO’s site description lists 260 bird species there, as well as Bengal tigers and estuarine crocodiles. — (voice only)

    Fonte ↗
O que é
Bangladesh’s WHO survival estimate is given as a band.
Seu diferencial
No edge over the other two is established by the supplied survival data.
Quem deve saber
Useful to readers comparing country estimates while noting evidence gaps.
  • Five-year breast cancer survival60–69%
Por que está aqui

  • WHO places Bangladesh in the 60–69% five-year survival band for 2017–2021, the same band as India and above Pakistan’s 50–59%. — (voice only)

    Fonte ↗

  • Across South-East Asia, WHO estimates median five-year survival at 66.3%; Bangladesh is among the five of 10 countries in the region in the 60–69% band. — (voice only)

    Fonte ↗
História

  • In 1970, Cyclone Bhola devastated East Pakistan. The disaster and the government’s weak relief response deepened anger; after a nine-month war, Pakistan surrendered in December 1971 and Bangladesh became independent.

    Fonte ↗
Para ter em mente

  • The WHO survival estimate is modelled from registry observations, country submissions and other information; the supplied sources give a band, not an exact national survival value.

    Fonte ↗
O que as pessoas dizem

  • “One day, I felt a different kind of pain on my breast.” — Dr. Akhtarunnessa Chowdhury

    Fonte ↗
Onde saber mais

  • Explore Bangladesh’s official cervical and breast cancer statistics dashboard; start with the screening charts, which show what the collected data covers. — (voice only)

    Fonte ↗
Comparar os três primeiros ↓

Os três primeiros lado a lado

PakistanIndiaBangladesh
Nas listas das IAs8 / 98 / 98 / 9
Five-year breast cancer survival50–59%66.1%60–69%
Primeiro paraClaude, ChatGPT, Qwen——

Posições com o mesmo número de IAs são ordenadas pela posição média nas listas das IAs.

Mais rankings

03Vale a pena saber

O que as IAs perceberam ao montar a lista.

A OMS estima sobrevivência mediana global de cinco anos de 77,8% para 2017–2021, com 87,3% nos países de alta renda e 41,9% nos de baixa renda.

Perceberam:
Incluíram: Claude, ChatGPT, Gemini. Não incluíram: Meta, Nemotron, Kimi, DeepSeek, Wenxin, Qwen.
Fonte ↗

O estudo de estágios em Lahore e a estimativa de sobrevivência da OMS descrevem coisas diferentes: uma coorte de um único hospital de referência não pode ser lida como taxa nacional de sobrevivência ou de estágio.

Perceberam:
Incluíram: Claude, ChatGPT, Kimi. Não incluíram: Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen.
Fonte ↗

A estimativa da OMS para a Nigéria passa de 27,7% para 47,7% quando se excluem os dados de registros hospitalares, o que mostra como os rankings de países podem depender da cobertura dos dados.

Perceberam:
Incluíram: ChatGPT, Nemotron, DeepSeek. Não incluíram: Claude, Meta, Gemini, Kimi, Wenxin, Qwen.
Fonte ↗

As razões entre mortes e casos novos são calculadas a partir de óbitos e casos; são uma verificação cruzada aproximada, não um substituto da sobrevivência de cinco anos.

Perceberam:
Incluíram: Claude, ChatGPT, Nemotron. Não incluíram: Meta, Gemini, Kimi, DeepSeek, Wenxin, Qwen.
Fonte ↗

04Como contamos

Em palavras simples, sem fórmulas.

1A pergunta

Top 10 Cricket Nations by the Breast Cancer Early-Detection Gap

2Por que este tema

It places survival and stage at diagnosis side by side for the countries in today's series and their cricket rivals, which no single survival or incidence table does.

3Onde se aplica

Test-playing and leading one-day cricket nations with published survival or stage data

4O que analisamos

  • Five-year age-standardised net survival for women with breast cancer
  • Share of cases diagnosed at an advanced stage (III–IV) compared with an early stage (I–II), from national registries or published studies
  • Mortality-to-incidence ratio as a cross-check where survival data are missing
  • WHO global breast cancer survival estimates — Predicted age-standardised five-year net survival for 2017–2021, using registry observations, country submissions and modelling; some results are bands.
  • CONCORD-3 — Five-year age-standardised net survival from population-based registries for women diagnosed 2010–2014; coverage varies by country.
  • National registries and published stage studies — Stage at diagnosis; hospital cohorts may not represent a whole country and staging methods differ.
  • IARC GLOBOCAN 2022 — Age-standardised breast cancer incidence and mortality per 100,000; mortality-to-incidence ratios calculated from these rates are only a rough cross-check, not survival estimates.

5Quem classificou

As IAs líderes: Claude, ChatGPT, Meta, Nemotron, Gemini, Kimi, DeepSeek, Wenxin, Qwen. Cada uma montou sua própria lista de dez de forma independente e indicou uma fonte para cada posição.

6Como as posições foram definidas

O mesmo item escrito de formas diferentes por IAs diferentes foi contado como um só. Quanto mais IAs o colocaram na lista, e quanto mais alto, mais alta a posição. "Acordo das IAs" mostra quantas IAs tinham o item na própria lista. As fontes são apenas as que as próprias IAs encontraram; nada foi acrescentado à mão.